FBLN1 and cardiomyopathy: Fibulin-1 mRNA expression is increased in a model of cardiomyopathy [5], and fibulin-1 plasma levels positively correlate with plasma N-terminal pro-B-type natriuretic peptide, a cardiac marker of pressure or volume overload [1,6].